Predicting Long-Term Engraftment of Engineered Immune Cells Through Tissue-Niche Adaptation

Speciality: Gene & Cell Therapy


Speaker:

Mr. Ashwin S Krishnan | HCP

Description:

Welcome to today’s episode, where we explore how predicting the long-term engraftment of engineered immune cells can transform modern medicine. Engraftment refers to the ability of these engineered cells to survive and function in a patient’s body over time. Scientists are discovering that tissue-niche adaptation—the process by which immune cells adjust to their new tissue environments—plays a critical role in this success. By understanding the signals and conditions that encourage adaptation, researchers can design more effective cell therapies for cancer, autoimmune diseases, and more. This approach not only improves treatment outcomes but also helps personalize therapies for individual patients. Stay with us to learn how this cutting-edge research is paving the way for the future of immune cell therapy.

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer during young adulthood carries long-term mental toll, study finds

2.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

3.

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot